EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Continuous multi‐column capture of monoclonal antibodies with convective diffusive membrane adsorbers

Fabian Schmitz, Elias Knöchelmann, Thomas Kruse, Mirjana Minceva iD, Markus Kampmann

Biotechnology and Bioengineering · 2024

DOI: 10.1002/bit.28695 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology and Bioengineering, 2024. Verfasst von Fabian Schmitz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Biothermodynamics, TUM School of Life Sciences, Technical University of Munich, Freising, Germany. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Membranes, Artificial, Cricetulus. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Downstream processing is the bottleneck in the continuous manufacturing of monoclonal antibodies (mAbs). To overcome throughput limitations, two different continuous processes with a novel convective diffusive protein A membrane adsorber (MA) were investigated: the rapid cycling parallel multi‐column chromatography (RC‐PMCC) process and the rapid cycling simulated moving bed (RC‐BioSMB) process. First, breakthrough curve experiments were performed to investigate the influence of the flow rate on the mAb dynamic binding capacity and to calculate the duration of the loading steps. In addition, customized control software was developed for an automated MA exchange in case of pressure increase due to membrane fouling to enable robust, uninterrupted, and continuous processing. Both processes were performed for 4 days with 0.61 g L −1 mAb‐containing filtrate and process performance, product purity, productivity, and buffer consumption were compared. The mAb was recovered with a yield of approximately 90% and productivities of 1010 g L −1 d −1 (RC‐PMCC) and 574 g L −1 d −1 (RC‐BioSMB). At the same time, high removal of process‐related impurities was achieved with both processes, whereas the buffer consumption was lower for the RC‐BioSMB process. Finally, the attainable productivity for perfusion bioreactors of different sizes with suitable MA sizes was calculated to demonstrate the potential to operate both processes on a manufacturing scale with bioreactor volumes of up to 2000 L.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, MonoclonalMembranes, ArtificialCricetulusAdsorptionCHO CellsBioreactorsStaphylococcal Protein AAnimalsChromatography, Affinity

Stichwörter der Autor:innen

affinity chromatographycontinuous downstream processingmembrane chromatographymonoclonal antibody purificationmulti‐column chromatography

Substanzen

Antibodies, MonoclonalMembranes, ArtificialStaphylococcal Protein A

Autor:innen und Institutionen

  • Biothermodynamics, TUM School of Life Sciences, Technical University of Munich, Freising, Germany.
  • Corporate Research, Sartorius Stedim Biotech GmbH, Göttingen, Germany.

ORCID-Profile: Mirjana Minceva

Zitieren

APA

Schmitz, F., Knöchelmann, E., Kruse, T., Minceva, M., & Kampmann, M. (2024). Continuous multi‐column capture of monoclonal antibodies with convective diffusive membrane adsorbers. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.28695

Vancouver

Schmitz F, Knöchelmann E, Kruse T, Minceva M, Kampmann M. Continuous multi‐column capture of monoclonal antibodies with convective diffusive membrane adsorbers. Biotechnology and Bioengineering. 2024. doi:10.1002/bit.28695

BibTeX
@article{Schmitz2024,
  author = {Schmitz, Fabian and Knöchelmann, Elias and Kruse, Thomas and Minceva, Mirjana and Kampmann, Markus},
  title = {Continuous multi‐column capture of monoclonal antibodies with convective diffusive membrane adsorbers},
  journal = {Biotechnology and Bioengineering},
  year = {2024},
  doi = {10.1002/bit.28695}
}
Kostenlos starten →